UCM uscom limited

0.00%

1.9¢

Ann: Amended Russian Regulatory Approval and Distribution, page-9

First 9 Last

Share
Profile

Follow
Lets Find Oil

307 Posts.

177

09/07/21

21:28

Post #: 54407840
Share

Originally posted by honeysoy: ↑

Fair points muya . The share price is almost exactly where it was in October 2011 so zero value added in almost 10 years so I can’t argue your facts.
The 1a life saving ICU device is a superb product that has carried the company but I am hopeful the new approval of devices and regions will help lift the sales and revenues which as you and nilnoony state are the be all and end all re credibility. I believe the bp plus was ce Mark approved for European sales back in December 2017 so not sure how much that has contributed re revenues. I think the 1a has been the shining light but perhaps the bp plus has had more European sales over the 3 1/2 yearsthen it seems to have had.
@nilnoony . Thanks for the heads up re today’s interview. Just listened. Solid and upbeat as always. Was not aware that the Uscom 1a was already in 40% of the top U.S hospitals. Credibility right there.
The interview lady pushed hard on the is it an Australian product made locally. I find it strange that the locally made devices like the 1a and bp plus get sold around the world but my local hospitals and doctor clinics don’t use them. So much for supporting life saving Australian medical devices but that’s another story across many industries that frustrates me.
Hopefully if they are able put the interview on their Facebook, LinkedIn and Twitter sites for extra exposure. They have failed to put the last 2 announcements on AAA credit and Russian approval on any so perhaps they won’t.
I agree- Sales , Revenues, Profits!!!!

Expand

Have dipped my toes in the water here.
This has massive potential. Just need to see if sales are secured over the next 12 months. First indication of sales and will load up.
Got to think there is good upside with limited downside.

UCM Price at posting: 16.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.9¢		Change 0.000(0.00%)		Mkt cap ! $4.759M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	500000	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	46000	1

View Market Depth

No.	Vol.	Price($)
1	500000	0.014
1	132270	0.012
1	100000	0.010
1	150000	0.008
2	2000000	0.001

Price($)	Vol.	No.
0.019	46000	1
0.020	63256	1
0.021	24866	1
0.022	6549	1
0.055	95083	2

Last trade - 16.21pm 27/06/2025 (20 minute delay)

UCM (ASX) Chart

Day chart unavailable

Ann: Amended Russian Regulatory Approval and Distribution, page-9

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Amended Russian Regulatory Approval and Distribution, page-9

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News